Cleared Traditional

Safety Blood Collection Needle (Without Needle Holder) (K222141) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222141 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
93d
Days
Class 2
Risk

K222141 is an FDA 510(k) clearance for the Safety Blood Collection Needle (Without Needle Holder). Classified as Tubes, Vials, Systems, Serum Separators, Blood Collection (product code JKA), Class II - Special Controls.

Submitted by Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. (Anqing City, CN). The FDA issued a Cleared decision on October 21, 2022 after a review of 93 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 862.1675 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. devices

Submission Details

510(k) Number K222141 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 20, 2022
Decision Date October 21, 2022
Days to Decision 93 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 129d · This submission: 93d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Irc
Charles Mack

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 100
Devices cleared under the same product code (JKA) and FDA review panel - the closest regulatory comparables to K222141.
Safety Push Button Blood Collection Set
K222834 · Jiangsu Caina Medical Co.,Ltd · Jan 2023
Steripath Micro Blood Collection System
K222299 · Magnolia Medical Technologies · Nov 2022
Eclipse Blood Collection Set
K213690 · Eclipse Medcorp, LLC · Oct 2022
Velano Vascular Blood Collection Adapter 
K201237 · Velano Vascular · Oct 2022
SOL-GUARD Safety Pull Button Collection Set
K213718 · Sol-Millennium Medical, Inc. · Aug 2022
K-SHIELD Zen
K220799 · Sb-Kawasumi Laboratories, Inc. · Aug 2022